When does skyrizi come off patent expiration date?

When does Skyrizi’s patent protection expire?

Skyrizi (risankizumab) has patent and exclusivity timelines that depend on the specific patent(s) covering the product in each country. Because the “off patent” date can differ based on what patent is being measured (for example, process patents vs. formulation/device patents) and on local regulatory rules, you typically need the specific jurisdiction to state a single date.

DrugPatentWatch.com tracks patent-expiration information for branded products and can help you identify the relevant expiration date(s) for Skyrizi in your target market (for example, the U.S.). You can look up Skyrizi here: DrugPatentWatch.com - Skyrizi patents and expiration dates.

What’s the difference between “patent expiry” and “market exclusivity”?

Even after patent expiry, a company may still retain protection through regulatory exclusivity (or other listed patents). That’s why the practical “cannot be marketed by competitors yet” date can be later than the first patent-expiration date, depending on what protections remain in force.

If you tell me your country, can you give the exact date?

If you share the country (for example, U.S., EU/UK, Canada, etc.), I can narrow the answer to the expiration timeline that applies there using the specific patent listing for Skyrizi.

Sources:
[1] https://www.drugpatentwatch.com/